Athens Medical CentreFRA:ACS -1.83%69 PS Ratio is 0.50 as of Jul. 05, 2026, which is 19% below its 10-year median of 0.62. GuruFocus rates FRA:ACS with a GF Score™ of 69/100 and a GF Value™ of €1.76 (Fairly Valued). The stock has 8 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Athens Medical Centre ranks better than 78.23% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Athens Medical Centre's share price is €1.605.
Athens Medical Centre's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €3.18. Hence, Athens Medical Centre's PS Ratio for today is 0.50.
Good Sign:
Athens Medical Centre SA stock PS Ratio (=0.56) is close to 1-year low of 0.52.
The historical rank and industry rank for Athens Medical Centre's PS Ratio or its related term are showing as below:
FRA:ACS'
s PS Ratio Range Over the Past 10 Years
Min: 0.29 Med: 0.62 Max: 1.11
Current: 0.56
During the past 13 years, Athens Medical Centre's highest PS Ratio was 1.11. The lowest was 0.29. And the median was 0.62.
FRA:ACS's PS Ratio is ranked better than 78.23% of 657
companies
in the Healthcare Providers & Services industry
Industry Median: 1.5
vs FRA:ACS: 0.56
Athens Medical Centre SA revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Athens Medical Centre was 2.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 5.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 7.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 6.20% per year.
During the past 13 years, Athens Medical Centre's highest 3-Year average Revenue per Share Growth Rate was 11.30% per year. The lowest was -15.20% per year. And the median was 4.65% per year.
Back to Basics: PS Ratio
Athens Medical Centre (FRA:ACS) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Athens Medical Centre's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Athens Medical Centre PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Athens Medical Centre's PS Ratio distribution charts can be found below:
* The bar in red indicates where Athens Medical Centre's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Athens Medical Centre's Share Price of today is €1.605.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Athens Medical Centre's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was €3.18.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Athens Medical Centre (FRA:ACS) has a PS Ratio of 0.50 as of Jul. 05, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Athens Medical Centre and its competitors. This is 19% below median its historical median of 0.62. Over the past decade, Athens Medical Centre's PS Ratio has ranged from 0.29 to 1.11. According to the industry distribution chart, Athens Medical Centre ranks #143 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 21.8%.
Is Athens Medical Centre's PS Ratio too high?
Athens Medical Centre's current PS Ratio of 0.50 is 19% below median its 10-year median of 0.62. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 1.11. The Healthcare Providers & Services industry median PS Ratio is 1.50. Athens Medical Centre's value of 0.50 is 66.7% below this industry median. Based on the distribution chart, Athens Medical Centre ranks #143 out of 657 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Athens Medical Centre has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Athens Medical Centre's PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Athens Medical Centre ranks #143 out of 657 companies for PS Ratio. This places Athens Medical Centre in the top 22% of its industry — outperforming the majority of peers. The industry median PS Ratio is 1.50. Athens Medical Centre's value of 0.50 is 66.7% below this benchmark. Historically, Athens Medical Centre's own PS Ratio has ranged from 0.29 to 1.11 over the past decade. While the company's 10-year median is 0.62 vs. the industry median of 1.50, Athens Medical Centre has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.50, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Athens Medical Centre's current PS Ratio of 0.50 is 66.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Athens Medical Centre and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athens Medical Centre's current PS Ratio is 0.50, which is 19% below median its own 10-year median of 0.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athens Medical Centre stock overvalued right now?
Based on GuruFocus' analysis, Athens Medical Centre (FRA:ACS) is currently considered Fairly Valued. The stock's GF Value™ is €1.76, compared to a current price of €1.61 — trading 8.8% below its estimated fair value. The current PS Ratio is 0.50, which is 19% below median its 10-year median of 0.62 and 66.7% below the Healthcare Providers & Services industry median of 1.50. Athens Medical Centre's overall GF Score™ is 69/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Athens Medical Centre (FRA:ACS), the current PS Ratio is 0.50 as of Jul. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Athens Medical Centre (FRA:ACS) Overvalued in 2026?
Based on GuruFocus' analysis, Athens Medical Centre stock appears to be undervalued.
The current stock price of €1.61 is trading 8.8% below its estimated GF Value™ of €1.76.
GuruFocus considers Athens Medical Centre to be Fairly Valued.
Key valuation signals for FRA:ACS:
PS Ratio: 0.50 (19% below median its 10-year median of 0.62)
GF Value™: €1.76 vs. price of €1.61 (8.8% below fair value)
Industry Position: 66.7% below the Healthcare Providers & Services median (#143 of 657)
No single metric tells the full story. See the FRA:ACS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Athens Medical Centre SA engages in the provision of healthcare services. It includes medical research and methods of treatment, training, and selection of executives and staff on behalf of the hospitals and importation of medical tools, instruments, machinery, and automated devices for the hospitals. Its offering includes medical services in such specializations as pathology, cardiology, general surgery, plastic and vascular surgery, orthopedic, physiotherapy, ophthalmology, urology, neurosurgery, thoracic, pediatric, dermatology, endocrinology and stomatology. The company operates in Domestic healthcare service, Healthcare service provided abroad (Romania) and Sale of medical tools & sanitary/health equipment segment.
69GF Score
Get the complete analysis for FRA:ACS
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:ACS has been successfully added to your 
